Report of the 2003 pan-Canadian forum on cervical cancer prevention and control
- PMID: 15560864
- DOI: 10.1016/s1701-2163(16)30423-6
Report of the 2003 pan-Canadian forum on cervical cancer prevention and control
Abstract
Objective: To develop evidence-based consensus recommendations on the delivery of cervical cancer screening, human papillomavirus (HPV) education, HPV testing, and the optimal tool for cervical cytology within the Canadian health system.
Participants: Leading up to a forum held in Ottawa on November 21 and 22, 2003, 254 registrants reviewed position papers through a Web-based discussion group. Experts in program management, clinical practice, epidemiology, public health, economics, and women's health, representing 48 organizations, then participated in the 2-day forum to develop consensus recommendations.
Evidence: Writing groups prepared position papers on optimal methods for cervical cytology; education concerning HPV; HPV testing in primary screening; HPV testing as a triage tool in cytopathology; and delivery mechanisms for cervical screening. Systematic reviews were the primary source of evidence supplemented by literature searches.
Consensus process: Feedback from Web-based discussions was incorporated into consecutive drafts of position papers. At the forum, recommendations and supporting evidence were presented, further debated in small-group sessions, and discussed in a plenary session. Despite divergent professional mandates and opinions, consensus was achieved on 15 recommendations across all areas. Final recommendations were posted to the Web for further input and circulated for written consensus by participants.
Conclusions: The recommendations cover the use of new evidence and technologies in cervical cancer prevention in Canada and provide a framework for provision of HPV education, planning the implementation of new cervical screening technologies in Canada, the development of evaluation plans, and new research areas.
Similar articles
-
Cervical cancer screening in the early post vaccine era.Obstet Gynecol Clin North Am. 2008 Dec;35(4):537-48; vii. doi: 10.1016/j.ogc.2008.09.005. Obstet Gynecol Clin North Am. 2008. PMID: 19061815 Review.
-
Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).Int J Cancer. 2006 Aug 1;119(3):615-23. doi: 10.1002/ijc.21897. Int J Cancer. 2006. PMID: 16572425 Clinical Trial.
-
Human papillomavirus and cervical disease in adolescents.Clin Obstet Gynecol. 2008 Jun;51(2):290-305. doi: 10.1097/GRF.0b013e318172d0dc. Clin Obstet Gynecol. 2008. PMID: 18463460 Review.
-
Human papillomavirus: emerging trends in detection and management.Curr Womens Health Rep. 2002 Aug;2(4):259-65. Curr Womens Health Rep. 2002. PMID: 12150752 Review.
-
Chapter 13: Primary screening of cervical cancer with human papillomavirus tests.J Natl Cancer Inst Monogr. 2003;(31):89-96. doi: 10.1093/oxfordjournals.jncimonographs.a003488. J Natl Cancer Inst Monogr. 2003. PMID: 12807951 Review.
Cited by
-
Prevalence of selected preventable and treatable diseases among government-assisted refugees: Implications for primary care providers.Can Fam Physician. 2007 Nov;53(11):1928-34. Can Fam Physician. 2007. PMID: 18000270 Free PMC article.
-
PD-L1+CD8+ T cells enrichment in lung cancer exerted regulatory function and tumor-promoting tolerance.iScience. 2022 Jan 19;25(2):103785. doi: 10.1016/j.isci.2022.103785. eCollection 2022 Feb 18. iScience. 2022. PMID: 35146396 Free PMC article.
-
Evolution of cervical cancer screening and prevention in United States and Canada: implications for public health practitioners and clinicians.Prev Med. 2013 Nov;57(5):426-33. doi: 10.1016/j.ypmed.2013.01.020. Epub 2013 Feb 8. Prev Med. 2013. PMID: 23402963 Free PMC article. Review.
-
Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis.BMC Med. 2009 Nov 9;7:69. doi: 10.1186/1741-7015-7-69. BMC Med. 2009. PMID: 19900264 Free PMC article.
-
Comparison of papanicolaou (Pap) test rates across Ontario and factors associated with cervical screening.Can J Public Health. 2005 Mar-Apr;96(2):140-4. doi: 10.1007/BF03403678. Can J Public Health. 2005. PMID: 15850036 Free PMC article.